Clinical trials

Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.

377 studies match

clinicaltrialsPublishedShowing 151–200 of 377 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03719690	Safety and Efficacy of Tipifarnib in Head and Neck Cancer With HRAS Mutations and Impact of HRAS on Response to Therapy(AIM-HN/SEQ-HN)	completed	Phase 2	296	Kura Oncology, Inc.INDUSTRY	16	Jun 21, 2024	clinicaltrials
NCT03610724	Phase II Open Label Trial to Determine Safety & Efficacy of Tisagenlecleucel in Pediatric Non-Hodgkin Lymphoma Patients(BIANCA)	completed	Phase 2	34	Novartis PharmaceuticalsINDUSTRY